SELLAS Life Sciences Group Inc. (NASDAQ: SLS) Stock Information | RedChip

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) Listen to this Section


$1.32
+0.0450 ( +3.54% ) 646.7K

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Market Data


Open


$1.32

Previous close


$1.27

Volume


646.7K

Market cap


$84.92M

Day range


$1.27 - $1.34

52 week range


$0.50 - $1.90

Insider Ownership Transactions

Total Amount Purchased: -295,119.00 | $ -388,081.49

Date Type Amount Purchased Purchaser
2024-01-25 Sale -6000.00 SCHEINBERG DAVID A
2024-01-25 Sale -6000.00 Kalin Katherine Bach
2024-01-25 Sale -6000.00 Wasman Jane
2024-01-25 Sale -20000.00 Francomano Robert
2024-01-25 Sale -6000.00 Varian John
2024-01-25 Sale -6000.00 VAN NOSTRAND ROBERT L
2024-01-25 Sale -47000.00 Burns John Thomas
2024-01-25 Sale -159000.00 Stergiou Angelos M.
2024-01-25 Sale -35000.00 WOOD BARBARA A
2023-12-08 Sale -4119.00 WOOD BARBARA A

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Aug 13, 2024
10-q Quarterly Reports 63 Aug 13, 2024
8-k 8K-related 20 Aug 01, 2024
3 Insider transactions 2 Jun 27, 2024
8-k 8K-related 13 Jun 21, 2024
8-k 8K-related 14 May 14, 2024
10-q Quarterly Reports 65 May 14, 2024
ars Annual reports 1 Apr 30, 2024
def Proxies and info statements 10 Apr 29, 2024
8-k 8K-related 13 Mar 28, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.